632625-43-5

Basic information

• Product Name: Benzoic acid, 3-[2-[5-chloro-2-(phenylmethoxy)phenyl]-5-methyl-1H-pyrrol-1-yl]-, ethyl ester
• CAS NO: 632625-43-5
• Molecular Formula: C27H24ClNO3
• Molecular Weight: 445.945
• Mol File: 632625-43-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-[2-[5-chloro-2-(phenylmethoxy)phenyl]-5-methyl-1H-pyrrol-1-yl]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-[2-[5-chloro-2-(phenylmethoxy)phenyl]-5-methyl-1H-pyrrol-1-yl]-, ethyl ester(632625-43-5)
• EPA Substance Registry System: Benzoic acid, 3-[2-[5-chloro-2-(phenylmethoxy)phenyl]-5-methyl-1H-pyrrol-1-yl]-, ethyl ester(632625-43-5)

Safety Data

• Hazardous Substances Data: 632625-43-5(Hazardous Substances Data)

Upstream product

• 635-93-8 5-chlorosalicyclaldehyde 
• 100-39-0 benzyl bromide 
• 38544-16-0 2-(benzyloxy)-5-chlorobenzaldehyde 

Downstream Products

• 632622-57-2 3-{2-[5-chloro-2-(benzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-N-methyl-N-[(R)-1-phenylethyl]benzamide 
• 632622-56-1 3-{2-[5-chloro-2-(benzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-N-[(R)-1-phenylethyl]benzamide 
• 632621-54-6 3-{2-[5-chloro-2-(benzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-benzoic acid 
• 902464-58-8 3-[5-(2-benzyloxy-5-chloro-phenyl)-3-bromo-2-methyl-pyrrol-1-yl]-benzoic acid 

Relevant articles and documents

Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists

Replacement of the carboxylic acid group in a series of previously described 1,5-biaryl pyrrole EP1 receptor antagonists led to the discovery of various novel non-acidic antagonists. Several analogues displayed high binding affinity and high bi

PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES

Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine, in particular their use in the treatment of prostaglandin mediated diseases such as pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.